156 related articles for article (PubMed ID: 24946986)
21. Leptin and adiponectin: emerging therapeutic targets in breast cancer.
Surmacz E
J Mammary Gland Biol Neoplasia; 2013 Dec; 18(3-4):321-32. PubMed ID: 24136336
[TBL] [Abstract][Full Text] [Related]
22. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis.
Endo H; Hosono K; Uchiyama T; Sakai E; Sugiyama M; Takahashi H; Nakajima N; Wada K; Takeda K; Nakagama H; Nakajima A
Gut; 2011 Oct; 60(10):1363-71. PubMed ID: 21406387
[TBL] [Abstract][Full Text] [Related]
23. Novel antineoplastics targeting genetic changes in colorectal cancer.
Joudeh J; Allen JE; Das A; Prabhu V; Farbaniec M; Adler J; El-Deiry WS
Adv Exp Med Biol; 2013; 779():1-34. PubMed ID: 23288633
[TBL] [Abstract][Full Text] [Related]
24. Adipokines as therapeutic targets in breast cancer treatment.
Cha YJ; Koo JS
Expert Opin Ther Targets; 2018 Nov; 22(11):941-953. PubMed ID: 30332900
[TBL] [Abstract][Full Text] [Related]
25. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells.
Hoda MR; Keely SJ; Bertelsen LS; Junger WG; Dharmasena D; Barrett KE
Br J Surg; 2007 Mar; 94(3):346-54. PubMed ID: 17212381
[TBL] [Abstract][Full Text] [Related]
26. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
Bordonaro M; Lazarova DL
World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
[TBL] [Abstract][Full Text] [Related]
27. Targeting PI3K signaling as a therapeutic approach for colorectal cancer.
Zhang J; Roberts TM; Shivdasani RA
Gastroenterology; 2011 Jul; 141(1):50-61. PubMed ID: 21723986
[TBL] [Abstract][Full Text] [Related]
28. K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
Nussinov R; Muratcioglu S; Tsai CJ; Jang H; Gursoy A; Keskin O
Expert Opin Ther Targets; 2016 Jul; 20(7):831-42. PubMed ID: 26873344
[TBL] [Abstract][Full Text] [Related]
29. Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.
Nyasani E; Munir I; Perez M; Payne K; Khan S
Endocrine; 2019 Jan; 63(1):3-17. PubMed ID: 30218381
[TBL] [Abstract][Full Text] [Related]
30. Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer.
Ko SY; Blatch GL; Dass CR
Cancer Metastasis Rev; 2014 Mar; 33(1):101-13. PubMed ID: 24338005
[TBL] [Abstract][Full Text] [Related]
31. Leptin signaling and cancer chemoresistance: Perspectives.
Candelaria PV; Rampoldi A; Harbuzariu A; Gonzalez-Perez RR
World J Clin Oncol; 2017 Apr; 8(2):106-119. PubMed ID: 28439492
[TBL] [Abstract][Full Text] [Related]
32. Leptin and its metabolic interactions: an update.
Anubhuti ; Arora S
Diabetes Obes Metab; 2008 Nov; 10(11):973-93. PubMed ID: 18284436
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and pharmacodynamic evaluation of aflibercept for the treatment of colorectal cancer.
Sanz-Garcia E; Saurí T; Tabernero J; Macarulla T
Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):995-1004. PubMed ID: 25988772
[TBL] [Abstract][Full Text] [Related]
34. Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.
Liu X; Ji Q; Fan Z; Li Q
Future Oncol; 2015; 11(21):2911-22. PubMed ID: 26414153
[TBL] [Abstract][Full Text] [Related]
35. The role of leptin in gastric cancer: clinicopathologic features and molecular mechanisms.
Lee KN; Choi HS; Yang SY; Park HK; Lee YY; Lee OY; Yoon BC; Hahm JS; Paik SS
Biochem Biophys Res Commun; 2014 Apr; 446(4):822-9. PubMed ID: 24569072
[TBL] [Abstract][Full Text] [Related]
36. Scutellaria Barbata D Don Inhibits Colorectal Cancer Growth via Suppression of Multiple Signaling Pathways.
Lin J; Chen Y; Cai Q; Wei L; Zhan Y; Shen A; Sferra TJ; Peng J
Integr Cancer Ther; 2014 May; 13(3):240-8. PubMed ID: 24231788
[TBL] [Abstract][Full Text] [Related]
37. Leptin's Pro-Angiogenic Signature in Breast Cancer.
Gonzalez-Perez RR; Lanier V; Newman G
Cancers (Basel); 2013 Sep; 5(3):1140-62. PubMed ID: 24202338
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer models for novel drug discovery.
Golovko D; Kedrin D; Yilmaz ÖH; Roper J
Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
[TBL] [Abstract][Full Text] [Related]
39. Linking obesity to colorectal cancer: recent insights into plausible biological mechanisms.
Guffey CR; Fan D; Singh UP; Murphy EA
Curr Opin Clin Nutr Metab Care; 2013 Sep; 16(5):595-600. PubMed ID: 23743611
[TBL] [Abstract][Full Text] [Related]
40. A potential role for hepcidin in obesity-driven colorectal tumourigenesis.
Phillips E; Horniblow RD; Poole V; Bedford M; Ward DG; Kirkham AJ; Tomlinson J; Iqbal TH; Tselepis C
Oncol Rep; 2018 Jan; 39(1):392-400. PubMed ID: 29115635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
